3.55亿美元!太阳制药收购Checkpoint Therapeutics

Medaverse
10 Mar

3月9日,太阳制药(Sun Pharma)和Checkpoint Therapeutics(纳斯达克:CKPT)宣布已达成协议,太阳制药将以3.55亿美元首付款收购Checkpoint,一家免疫疗法和靶向肿瘤公司。Checkpoint是一家在纳斯达克上市的商业阶段公司,专注于为实体瘤患者开发新的治疗方法。Checkpoint开发的PD-L1抗体UNLOXCIT™(cosibelimab ipdl)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10